WAM
WNY Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $296K | Buy |
6,395
+272
| +4% | +$12.6K | 0.03% | 185 |
|
|
2025
Q1 | $373K | Buy |
6,123
+671
| +12% | +$40.9K | 0.04% | 167 |
|
|
2024
Q4 | $308K | Sell |
5,452
-2,630
| -33% | -$149K | 0.04% | 169 |
|
|
2024
Q3 | $418K | Sell |
8,082
-449
| -5% | -$23.2K | 0.05% | 162 |
|
|
2024
Q2 | $354K | Buy |
8,531
+469
| +6% | +$19.5K | 0.05% | 173 |
|
|
2024
Q1 | $437K | Buy |
8,062
+39
| +0.5% | +$2.12K | 0.07% | 156 |
|
|
2023
Q4 | $412K | Sell |
8,023
-80
| -1% | -$4.11K | 0.07% | 158 |
|
|
2023
Q3 | $470K | Buy |
8,103
+1,047
| +15% | +$60.8K | 0.09% | 140 |
|
|
2023
Q2 | $451K | Sell |
7,056
-192
| -3% | -$12.3K | 0.1% | 130 |
|
|
2023
Q1 | $502K | Sell |
7,248
-364
| -5% | -$25.2K | 0.12% | 120 |
|
|
2022
Q4 | $548K | Buy |
7,612
+41
| +0.5% | +$2.95K | 0.15% | 105 |
|
|
2022
Q3 | $537K | Sell |
7,571
-19
| -0.3% | -$1.35K | 0.2% | 95 |
|
|
2022
Q2 | $585K | Sell |
7,590
-354
| -4% | -$27.3K | 0.2% | 89 |
|
|
2022
Q1 | $578K | Sell |
7,944
-198
| -2% | -$14.4K | 0.18% | 95 |
|
|
2021
Q4 | $504K | Sell |
8,142
-1,328
| -14% | -$82.2K | 0.15% | 100 |
|
|
2021
Q3 | $564K | Buy |
9,470
+1,233
| +15% | +$73.4K | 0.19% | 88 |
|
|
2021
Q2 | $552K | Buy |
8,237
+728
| +10% | +$48.8K | 0.2% | 84 |
|
|
2021
Q1 | $472K | Buy |
7,509
+2,868
| +62% | +$180K | 0.19% | 76 |
|
|
2020
Q4 | $288K | Buy |
+4,641
| New | +$288K | 0.15% | 72 |
|